For more than 100 years, RIVMNational Institute for Public Health and the Environment has been promoting public health and safeguarding a healthy and safe environment. We have a central role in infectious disease control, national prevention and population screening programmes and monitoring our population’s health and the state of our environment. We support citizens, professionals and national and local authorities in the challenge of keeping ourselves and our environment healthy, safe and sustainable. Our ambition is to be a trusted advisor using independent research as the basis for our advisory work. Below we present some of the global challenges we work on and elaborate on our tasks and international activities.
Highlighted themes
Climate change and health
Climate change and health
Food and Nutrition
Safe, healthy and sustainable food
Antibiotic resistance
Antimicrobial Resistance (AMR)
Population screening programmes
Population Screening programmes
Circular economy
Circular Economy
Immunisation and vaccination
Immunisation and vaccination
What we do
International collaboration
International collaboration
National tasks and activities
National tasks and activities
International projects and networks
International projects and networks
COVID-19 in the Netherlands
RIVMNational Institute for Public Health and the Environment advises the Dutch government on how to control the coronavirus as effectively as possible, monitors the COVID-19 outbreak and conducts research into SARS-CoV-2. RIVM is coordinating the implementation of the COVID-19 vaccinations in the Netherlands. Our institute is responsible for coordinating the storage and distribution of COVID-19 vaccines in the Netherlands (including the islands of Aruba, Bonaire, St Eustatius, Saba, Curaçao and St Maarten).
We provide weekly updates and data on COVID-19 in the Netherlands. In addition to our general COVID-19 weekly epidemiological update, we also publish a COVID-19 weekly update for the CAS and BES islands: the islands of Curaçao, Aruba and Sint Maarten and the special municipalities Bonaire, Sint Eustatius and Saba.
Would you like to be kept informed on our work and activities? Subscribe to our quarterly newsletter. Read our international newsletter issue 1, 2021.
News
COVID-19 vaccination very effective: major drop in positive tests, hospital admissions and deaths among older people
People over 75 years old living at home are 82% protected against testing positive for COVID-19 from three weeks after the second vaccination.
Launch of the European project RISK-HUNT3R
The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.
Effects of COVID-19 vaccination becoming increasingly visible
In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.
At least 87% of people over 65 vaccinated at least once: high turnout, few regional differences
Four months after the launch of the vaccination campaign, at least 87% of people over 65 in the Netherlands have been vaccinated against COVID-19 at least once.
Quality assessment of SARS-CoV-2 antigen test diagnostics: good performance at public test sites in the Netherlands
In their role as WHO reference laboratories, RIVM and Erasmus UMC conducted a
Long-term symptoms more common after Lyme disease
More than a quarter of people with Lyme disease continue to have long-term symptoms that lead to limitations in daily life even after treatment.
